Microlife, a global leader in medical device development and manufacturing, is delighted to announce the successful attainment of the EU Medical Device Regulation (MDR) certification. This prestigious certificate was granted by the SGS (NB1639), reaffirming Microlife's commitment to delivering high-quality medical devices that meet the stringent regulatory standards of the European Union.
The EU MDR certification is a significant milestone for Microlife, demonstrating the company's dedication to excellence, compliance with European market regulations, and reinforcing its commitment to maintaining industry-leading standards in quality management, manufacturing, and product quality control. It enhances market access in EU member states, solidifying Microlife's leadership in the global medical device industry whilst assuring product safety, effectiveness and compliance with EU regulations.
"We are pleased to announce the successful certification under the EU Medical Device Regulation," said Albert Lim, CEO at Microlife. "This accomplishment reflects our commitment to delivering innovative and high-quality medical devices that meet the most stringent regulatory standards. We are proud to continue our mission of improving healthcare worldwide and expanding our presence in the European market."
Microlife remains dedicated to providing healthcare professionals and patients with reliable and innovative medical devices that enhance patient care and outcomes. This EU MDR certification is a proof to Microlife's relentless pursuit of excellence.
About Microlife:
Microlife is a global leader in medical diagnostic equipment for home and healthcare settings. We transform medical knowledge into innovative technology, allowing consumers to easily, safely, and accurately assess their health. Committed to a clinical, value-based approach, we work with authorised distributors in 100+ countries, creating a robust global network.